PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-101.75%
Negative net income growth while JHX stands at 212.45%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-48.94%
Both reduce yoy D&A, with JHX at -4.26%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
No Data
No Data available this quarter, please select a different quarter.
30.17%
Less SBC growth vs. JHX's 135.90%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-455.12%
Both reduce yoy usage, with JHX at -401.35%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
100.00%
AR growth well above JHX's 119.09%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
66.87%
Some inventory rise while JHX is negative at -173.68%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce yoy usage, with JHX at -384.85%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-76.09%
Both negative yoy, with JHX at -126.10%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-121.11%
Both yoy CFO lines are negative, with JHX at -24.67%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
64.19%
Some CapEx rise while JHX is negative at -108.21%. John Neff would see competitor possibly building capacity while we hold back expansions.
93.40%
Some acquisitions while JHX is negative at -100.00%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
93.55%
Purchases well above JHX's 64.55%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
No Data
No Data available this quarter, please select a different quarter.
-107.30%
We reduce yoy other investing while JHX is 99.71%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
83.83%
We have mild expansions while JHX is negative at -22.06%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
118.93%
Debt repayment 1.25-1.5x JHX's 87.91%. Bruce Berkowitz would see an edge in lowering interest burdens unless competitor invests in profitable expansions.
-80.00%
Both yoy lines negative, with JHX at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
54.78%
Buyback growth of 54.78% while JHX is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.